|
"wu sy"的相關文件
顯示項目 156-180 / 192 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2008-12-25 |
Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents
|
Reddy, GR;Kuo, CC;Tan, UK;Coumar, MS;Chang, CY;Chiang, YK;Lai, MJ;Yeh, JY;Wu, SY;Chang, JY;Liou, JP;Hsieh, HP |
| 國立臺灣大學 |
2008-11 |
YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway.
|
Wu, SY; Pan, SL; Chen, TH; Liao, CH; Huang, DY; Guh, JH; Chang, YL; Kuo, SC; Lee, FY; Teng, CM. |
| 國家衛生研究院 |
2008-08 |
A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors
|
Lu, IL;Tsai, KC;Chiang, YK;Jiaang, WT;Wu, SH;Mahindroo, N;Chien, CH;Lee, SJ;Chen, X;Chao, YS;Wu, SY |
| 國家衛生研究院 |
2008-07-21 |
吡咯啉啶化合物
|
Jiaang, WT;Wu, SY;Chen, X;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2008-07-01 |
Pyrrolidine compounds
|
Jiaang, WT;Chen, X;Wu, SY;Hsieh, HP;Chao, YS |
| 國家衛生研究院 |
2008-04 |
Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells
|
Hsu, M; Wu, SY; Chang, SS; Su, IJ; Tsai, CH; Lai, SJ; Shiau, AL; Takada, K; Chang, Y |
| 國家衛生研究院 |
2008-03-01 |
Aurora kinase A inhibitors: Identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold
|
Coumar, MS; Wu, JS; Leou, JS; Tan, UK; Chang, CY; Chang, TY; Lin, WH; Hsu, JTA; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2008 |
Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases
|
Kuo, CJ; Guo, RT; Lu, IL; Liu, HG; Wu, SY; Ko, TP; Wang, AHJ; Liang, PH |
| 臺北醫學大學 |
2008 |
Synthesis and Structure-Activity Relationships of 2-Amino and 2-Hydroxy-1-Aroylnaphthalenes as Potent Antitubulin Agents
|
劉景平; Reddy GR; Kuo CC; Tan UK; Coumar MS; Chang CY; Lai MJ; Wu SY; Chang JY; Liou JP; Hsieh HP |
| 臺北醫學大學 |
2008 |
Domain and Functional Analysis of a Novel Platelet-Endothelial Cell Surface Protein; SCUBE1.
|
鄭建睿; Tu CF; Yan YT; Wu SY; Djoko B; Tsai MT; Cheng CJ; Yang RB |
| 國立臺灣大學 |
2008 |
Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.
|
Hsu, M; Wu, SY; Chang, SS; Su, IJ; Tsai, CH; Lai, SJ; Shiau, AL; Takada, K; Chang, Y |
| 國家衛生研究院 |
2007 |
Crystal structures and computer screened inhibitors of Helicobacter pylori undecaprenyl pyrophosphate synthase
|
Kuo, CJ;Guo, RT;Lu, IL;Liu, HG;Wu, SY;Ko, TP;Wang, AHJ;Liang, PH |
| 臺北醫學大學 |
2007 |
Menthol inhibits WEHI-3 leukemia cells in vitro and in vivo
|
楊沂淵; Lu HF; Liu JY; Hsueh SC; Yang YY; Yang JS; Tan TW; Kok LF; Lu CC; Lan SH; Wu SY; et al.; |
| 國家衛生研究院 |
2006-10-19 |
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists
|
Mahindroo, N; Peng, YH; Lin, CH; Tan, UK; Prakash, E; Lien, TW; Lu, IL; Lee, HJ; Hsu, JTA; Chen, X; Liao, CC; Lyu, PC; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2006-08-24 |
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease
|
Lu, IL; Mahindroo, N; Liang, PH; Peng, YH; Kuo, CJ; Tsai, KC; Hsieh, HP; Chao, YS; Wu, SY |
| 國家衛生研究院 |
2006-08 |
Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta
|
Chang, Y; Lee, HH; Chen, YT; Lu, J; Wu, SY; Chen, CW; Takada, K; Tsai, CH |
| 國家衛生研究院 |
2006-06-15 |
Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies
|
Tsai, KC; Chen, SY; Liang, PH; Lu, IL; Mahindroo, N; Hsieh, HP; Chao, YS; Liu, L; Liu, D; Lien, W; Lin, TH; Wu, SY |
| 國家衛生研究院 |
2006-05-04 |
Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities
|
Lu, IL; Huang, CF; Peng, YH; Lin, YT; Hsieh, HP; Chen, CT; Lien, TW; Lee, HJ; Mahindroo, N; Prakash, E; Yueh, A; Chen, HY; Goparaju, CMV; Chen, X; Liao, CC; Chao, YS; Hsu, JTA; Wu, SY |
| 國家衛生研究院 |
2006-02-09 |
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies
|
Mahindroo, N; Wang, CC; Liao, CC; Huang, CF; Lu, IL; Lien, TW; Peng, YH; Huang, WJ; Lin, YT; Hsu, MC; Lin, CH; Tsai, CH; Hsu, JTA; Chen, X; Lyu, PC; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2006-01-12 |
2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV
|
Tsu, H; Chen, X; Chen, CT; Lee, SJ; Chang, CN; Kao, KH; Coumar, MS; Yeh, YT; Chien, CH; Wang, HS; Lin, KT; Chang, YY; Wu, SH; Chen, YS; Lu, IL; Wu, SY; Tsai, TY; Chen, WC; Hsieh, HP; Chao, YS; Jiaang, WT |
| 國立臺灣大學 |
2006-01 |
Population ecology of the southeastern Asian house mouse (Musmusculus castaneus) inhabiting rice granaries in Taiwan.
|
Wu, SY; Lin, YTK; Yu, HT |
| 國立臺灣大學 |
2006-01 |
Population ecology of house mouse (Mus musculus castaneus) inhabiting rice granaries in Taiwan.
|
Wu, SY; Lin, YK; Yu, HT |
| 國立臺灣大學 |
2006 |
Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.
|
Chang, Y; Lee, HH; Chen, YT; Lu, J; Wu, SY; Chen, CW; Takada, K; Tsai, CH |
| 國家衛生研究院 |
2005-12-29 |
Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities
|
Mahindroo, N; Huang, CF; Peng, YH; Wang, CC; Liao, CC; Lien, TW; Chittimalla, SK; Huang, WJ; Chai, CH; Prakash, E; Chen, CP; Hsu, TA; Peng, CH; Lu, IL; Lee, LH; Chang, YW; Chen, WC; Chou, YC; Chen, CT; Goparaju, CMV; Chen, YS; Lan, SJ; Yu, MC; Chen, X; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2005-12-15 |
The effect of N-terminal truncation on double-dimer assembly of goose delta-crystallin
|
Lee, HJ; Lai, YH; Wu, SY; Chen, YH |
顯示項目 156-180 / 192 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目
|
